Page last updated: 2024-11-05

methyl butyrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Methyl butyrate is an ester with the formula CH3CH2CH2COOCH3. It is a colorless liquid with a fruity odor, reminiscent of apples. Methyl butyrate occurs naturally in various fruits and fermented products. It is also produced synthetically by the esterification of butyric acid with methanol. Methyl butyrate has been studied for its potential applications as a flavoring agent in food and beverages, as well as its potential use in pharmaceuticals and cosmetics. It has been reported to exhibit antimicrobial activity against certain bacteria and fungi. Research interest in methyl butyrate is driven by its natural occurrence, flavor properties, and potential biological activities.'

Cross-References

ID SourceID
PubMed CID12180
CHEMBL ID15859
CHEBI ID88806
SCHEMBL ID13685
MeSH IDM0128503

Synonyms (68)

Synonym
unii-cgx598508o
4-02-00-00786 (beilstein handbook reference)
methyl butyrate [un1237] [flammable liquid]
cgx598508o ,
LS-13072
AKOS008907317
butanoic acid, methyl ester
butyric acid, methyl ester
n-butyric acid methyl ester
brn 1740743
methyl n-butanoate
fema no. 2693
hsdb 5721
nsc 9380
un1237
methyl butyrate (natural)
methyl-n-butyrate
einecs 210-792-1
ai3-06009
623-42-7
methyl butyrate
nsc9380
wln: 3vo1
methyl n-butyrate
nsc-9380
methyl butanoate
inchi=1/c5h10o2/c1-3-4-5(6)7-2/h3-4h2,1-2h
methyl butyrate, natural, >=98%, fg
methyl butyrate, >=98%, fg
methyl butyrate, 99%
5ADC8486-F8C0-4A7A-ACD5-2234D52DE6E0
butanoic acid methyl ester
butyric acid methyl ester
B0763
CHEMBL15859
chebi:88806 ,
we(1:0/4:0)
LMFA07010528
dtxcid3027083
dtxsid5047083 ,
cas-623-42-7
tox21_301821
NCGC00256040-01
FT-0628708
methanol - ethyl acetate
methyl 3-methylpropionate
methanol i ethyl acetate
SCHEMBL13685
methyl butyrate [mi]
methyl butyrate [fcc]
methyl n-butyrate [hsdb]
methyl butyrate [fhfi]
4-methylumbelliferyl-n-acetyl-beta-d-galactosaminidehydrate
un 1237
methyl ester of butanoic acid
n-c3h7cooch3
mfcd00009391
J-522595
n-butyric acid methyl ester [standard material]
methyl butyrate, certified reference material, tracecert(r)
methyl butyrate, analytical standard
butyric acid methylester
butyric acid-methyl ester
c04 fame
Q420701
EN300-70279
n-butyric acid, methyl ester
methyl-n-butanoate

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" The proposed study protocol will investigate the effects of HMB-calcium (HMB-Ca) administered in combination with comprehensive cardiac rehabilitation for muscle strength, muscle mass and cardiac function in patients with cardiac disease during the convalescent period."( Effects of beta-hydroxy beta-methyl butyrate calcium combined with exercise therapy in patients with cardiac disease: a study protocol for clinical trial.
Abe, S; Aimoto, K; Hachisu, M; Ichikawa, H; Iguchi, A; Ikeda, T; Inoue, E; Iso, Y; Miyazawa, R; Nakamura, D; Nakamura, S; Tashiro, N, 2023
)
1.2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
fatty acid esterA carboxylic ester in which the carboxylic acid component can be any fatty acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency68.58960.006038.004119,952.5996AID1159521
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency1.94940.000214.376460.0339AID720691
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (15.15)18.7374
1990's0 (0.00)18.2507
2000's3 (9.09)29.6817
2010's11 (33.33)24.3611
2020's14 (42.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.55 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index5.49 (4.65)
Search Engine Demand Index91.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (5.71%)5.53%
Reviews1 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (91.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]